Enanta's RSV antiviral crushes viral load in challenge study.

MLA

Taylor, Nick Paul. “Enanta’s RSV Antiviral Crushes Viral Load in Challenge Study.” FierceBiotech, Sept. 2024, p. N.PAG. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=179973482&authtype=sso&custid=ns315887.

APA

Taylor, N. P. (2024). Enanta’s RSV antiviral crushes viral load in challenge study. FierceBiotech, N.PAG.

Chicago

Taylor, Nick Paul. 2024. “Enanta’s RSV Antiviral Crushes Viral Load in Challenge Study.” FierceBiotech, September, N.PAG. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=179973482&authtype=sso&custid=ns315887.